Here's Why Axovant Sciences Stock Skyrocketed Today [The Motley Fool]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: The Motley Fool
Can the company treat Parkinson's disease with gene therapy? Maxx Chatsko ( TMFBlacknGold ) Jun 7, 2018 at 12:10PM What happened Development-stage biopharma Axovant Sciences ( NASDAQ:AXON ) opened 2018 by dropping devastating news on shareholders, essentially hinting that its neuro-drug pipeline was next to worthless . Shares responded as one might expect -- falling from over $20 apiece in late 2017 to just over $1 each in recent months. Turns out, that just set the stage for the stock's incredible run this month. Shares rose over 44% today -- and have gained 278% in June 2018 alone -- after Axovant Sciences announced that it will license the rights to a gene therapy drug candidate being evaluated as a potential treatment for Parkinson's disease. It also hired Dr. Fraser Wright, co-founder and former CTO of gene therapy pioneer Spark Therapeu
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise (AXON) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise Insiders Placed Bullish Bets Worth US$8.74m [Yahoo! Finance]Yahoo! Finance
- Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at JPMorgan Chase & Co. from $330.00 to $365.00. They now have an "overweight" rating on the stock.MarketBeat
- Axon Enterprise (AXON) Banks on Solid Product Demand Amid Risks [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEFA14A
- 4/2/24 - Form 4
- AXON's page on the SEC website